Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Dror Yigael"'
Publikováno v:
Cancer. 94:3101-3106
BACKGROUND Ultrasonography has a limited value in endometrial assessment for identification of endometrial pathologies in postmenopausal tamoxifen-treated patients. METHODS We compared the rate of endometrial pathologies and the mean ± SD of endomet
Autor:
A. Fishman, Jeremiah Shapira, Ilan Cohen, Ron Tepper, Mario Cordoba, Dror Yigael, Joelle Bernheim, Marco M. Altaras, Yoram Beyth
Publikováno v:
Gynecologic and Obstetric Investigation. 46:116-122
In order to assess possible ovarian cell potential for interaction with tamoxifen, thus demonstrating possible effects of this agent on the development of ovarian pathologies through growth stimulation and cell proliferation, we measured estrogen rec
Autor:
Ilan Cohen, Mario Cordoba, Joelle Bernheim, Yoram Beyth, Dror Yigael, Rami Aviram, Marco M. Altaras, Arie Figer, Jeremiah Shapira
Publikováno v:
Gynecologic and Obstetric Investigation. 46:123-129
Tamoxifen administration to postmenopausal women has been described as being associated with various endometrial and other gynecological pathologies. However, different coexisting gynecological pathologies in such patients have not yet been described
Autor:
Marco M. Altaras, Joelle Bernheim, Mario Cordoba, A. Fishman, Dror Yigael, Ilan Cohen, Ron Tepper, Yoram Beyth, Jeremiah Shapira
Publikováno v:
Gynecologic and Obstetric Investigation. 44:200-205
Pathologic evaluation for adenomyosis in uterine specimens as well as demographic characteristics, health habits and risk factors for endometrial cancer were compared in 28 postmenopausal breast cancer patients with tamoxifen (TAM) treatment and in 1
Autor:
Jeremiah Shapira, Ronnie Tepper, Yoram Beyth, Marco M. Altaras, Y. Zalel, Arie Figer, Dror Yigael, Ilan Cohen, Doron J.D. Rosen, Mario Cordoba
Publikováno v:
International Journal of Gynecological Pathology. 15:152-157
Various endometrial lesions were more frequent among asymptomatic postmenopausal breast cancer patients who were treated with tamoxifen for > 48 consecutive months (30.8%) when compared with similar patients who were treated for 6-24 months or for 25
Autor:
Mario Cordoba, Ilan Cohen, Dror Yigael, Ron Tepper, Jeremiah Shapira, Yaron Zalel, Arie Figer, Yoram Beyth, Marco M. Altaras
Publikováno v:
Gynecologic Oncology. 60:54-58
From September 1, 1989, to November 30, 1994, 175 menopausal breast cancer patients treated with tamoxifen were followed at the authors' institutions. During this period. 16 (9.1%) underwent total abdominal hysterectomy and bilateral salpingo-oophore
Autor:
Ilan Cohen, Yoram Beyth, Mario Cordoba, Dror Yigael, Jeremiah Shapira, Marco M. Altaras, Ron Tepper, Arie Figer
Publikováno v:
Gynecologic Oncology. 58:86-91
Between September 1, 1989 and October 31, 1994, 173 postmenopausal breast cancer women on tamoxifen treatment were followed up in the authors' institutions. During this period, 14 (8.1%) underwent total abdominal hysterectomy and bilateral salpingo-o
Autor:
Marco M. Altaras, Yoram Beyth, Doron J.D. Rosen, Jermia Shapira, Dror Yigael, Ilan Cohen, Shlomo Gilboa, Mario Cordoba
Publikováno v:
Gynecologic Oncology. 52:185-190
Endometrial thickness, as evaluated by vaginal ultrasonography, and endometrial histologic findings, as well as demographic characteristics, health habits, and risk factors for endometrial cancer, were compared between 93 asymptomatic postmenopausal
Publikováno v:
Radiology. 227(3)
To assess the long-term natural history of simple ovarian cysts diagnosed in postmenopausal patients with breast carcinoma treated with tamoxifen citrate.Of 332 postmenopausal women with breast cancer who were treated with tamoxifen, 32 (9.6%) had si
Publikováno v:
Gynecologic oncology. 72(2)
Aim. Tamoxifen is the antihormonal treatment of choice for premenopausal breast cancer patients with advanced breast disease. Its premenopausal administration has been shown to induce supraphysiological 17β-estradiol serum levels and to be associate